Company Performance Metrics
John Wilson: Chief Security Officer- Ruud Huisman: CFO
MYCB1 Group B.V, founded in 2017, is a health technology scale-up company that focuses on offering a diverse range of medications and services, including personalized options. Our innovative approach synergistically merges pharmaceutical manufacturing, pharmacy operations, and cutting-edge software engineering to drive evidence-based,
patient-centric healthcare solutions.
In conjunction, we are developing ALETTA, a cutting-edge digital personal assistant that actively helps users with ultra-personalized health recommendations. It harnesses the power of available generative AI and real-world evidence (RWE) to address the endemic problem of poor scientific evidence and personalization in the healthcare and lifestyle industries, ultimately fostering evidence-based decision-making and optimizing individual health outcomes.
Our mission is to make healthcare and lifestyle decisions data-driven and ultra-personalized; to save lives, reducing costs, improving outcomes, and laying the foundation for personalized medicine, globally.
